Showing 1 - 11 results of 11 for search 'Bamberg, M', query time: 0.02s
Refine Results
-
1
-
2
PCV salvage chemotherapy for recurrent primary CNS lymphoma. by Herrlinger, U, Brugger, W, Bamberg, M, Küker, W, Dichgans, J, Weller, M
Published 2000Journal article -
3
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. by Wick, W, Steinbach, J, Küker, WM, Dichgans, J, Bamberg, M, Weller, M
Published 2004Journal article -
4
Leptomeningeal metastasis: survival and prognostic factors in 155 patients. by Herrlinger, U, Förschler, H, Küker, W, Meyermann, R, Bamberg, M, Dichgans, J, Weller, M
Published 2004Journal article -
5
Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. by Küker, W, Nägele, T, Korfel, A, Heckl, S, Thiel, E, Bamberg, M, Weller, M, Herrlinger, U
Published 2005Journal article -
6
Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study. by Wick, W, Hermisson, M, Kortmann, R, Küker, WM, Duffner, F, Dichgans, J, Bamberg, M, Weller, M
Published 2002Journal article -
7
Primary central nervous system (CNS) lymphoma in immunocompetent patients. by Plasswilm, L, Herrlinger, U, Korfel, A, Weller, M, Küker, W, Kanz, L, Thiel, E, Bamberg, M
Published 2002Journal article -
8
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report. by Herrlinger, U, Küker, W, Uhl, M, Blaicher, H, Karnath, H, Kanz, L, Bamberg, M, Weller, M
Published 2005Journal article -
9
Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. A phase II study. by Weller, M, Streffer, J, Wick, W, Kortmann, R, Heiss, E, Küker, W, Meyermann, R, Dichgans, J, Bamberg, M
Published 2001Journal article -
10
Gliomatosis cerebri: molecular pathology and clinical course. by Herrlinger, U, Felsberg, J, Küker, W, Bornemann, A, Plasswilm, L, Knobbe, C, Strik, H, Wick, W, Meyermann, R, Dichgans, J, Bamberg, M, Reifenberger, G, Weller, M
Published 2002Journal article -
11
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. by Herrlinger, U, Schabet, M, Brugger, W, Kortmann, R, Küker, W, Deckert, M, Engel, C, Schmeck-Lindenau, H, Mergenthaler, H, Krauseneck, P, Benöhr, C, Meisner, C, Wiestler, O, Dichgans, J, Kanz, L, Bamberg, M, Weller, M
Published 2002Journal article